Biotech Clinical Research in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Biotech Clinical Research in Brazil

Biotech Clinical Research in Brazil – Full Service CRO

Brazil, a country renowned for its breathtaking landscapes, vibrant culture, and passionate people, is emerging as a significant player in the world of biotech clinical research.

As biotechnology continues to revolutionize healthcare, Brazil has positioned itself as an attractive destination for conducting clinical trials. This South American giant offers a unique blend of advantages, including a diverse patient population, skilled healthcare professionals, robust regulatory frameworks, and a vibrant research ecosystem.

In this blog, we will delve into the burgeoning landscape of biotech clinical research in Brazil, shedding light on its growth, benefits, challenges, and promising future.

The Evolving Biotech Landscape in Brazil

In recent years, Brazil has witnessed a substantial growth in its biotech sector. Several key factors contribute to the expanding landscape of biotech clinical research:

  1. Geographic Diversity: Brazil’s vast size and geographic diversity make it an ideal location for clinical trials, allowing researchers to study diseases and conditions influenced by various environments and climates.
  2. Diverse Patient Population: With a population exceeding 200 million, Brazil offers a diverse gene pool that can accommodate a wide range of research needs, making it an attractive destination for multinational clinical trials.
  3. Highly Trained Workforce: The country boasts a well-educated and trained healthcare workforce, including clinical researchers, physicians, and laboratory experts who are well-prepared to meet international standards.
  4. Cost-Effective Operations: Conducting clinical trials in Brazil is often more cost-effective than in many Western countries, allowing biotech companies to maximize their research budgets without compromising on quality.
  5. Regulatory Support: Brazil’s regulatory agency, ANVISA (Agência Nacional de Vigilância Sanitária), has been actively working to streamline processes and align with international standards, making it easier for companies to obtain approvals and conduct research.

Advantages of Conducting Biotech Clinical Research in Brazil

  1. Diverse Patient Demographics: Brazil’s population represents a wide range of ethnic backgrounds and genetic diversity, providing researchers with valuable insights into the applicability of treatments across different patient groups.
  2. Efficient Patient Recruitment: Brazil’s substantial population facilitates efficient patient recruitment, reducing the time and costs associated with clinical trials.
  3. Cost Efficiency: Clinical research operations in Brazil are generally more cost-efficient than in high-cost regions, making it a financially attractive option for biotech companies.
  4. Modern Infrastructure: Brazil boasts state-of-the-art research centers, well-equipped hospitals, and advanced laboratories, ensuring that research is conducted to the highest standards.
  5. Collaborative Ecosystem: Brazil’s burgeoning biotech ecosystem promotes collaboration among local and international researchers, facilitating knowledge exchange and fostering innovation.

Challenges in Biotech Clinical Research in Brazil

While Brazil offers numerous advantages, it also presents several challenges that researchers and companies must navigate:

  1. Complex Regulatory Environment: Adhering to Brazil’s regulatory landscape can be complex and demanding, necessitating a thorough understanding of local and international regulations.
  2. Language Barrier: While English is spoken among professionals, language barriers can occasionally pose communication challenges.
  3. Logistical Complexities: Managing logistics for clinical trials in a foreign country can be challenging, requiring meticulous planning and execution.
  4. Cultural Sensitivity: Understanding and respecting Brazilian culture and healthcare practices are vital for building trust among participants and stakeholders.

Biotech Clinical Research in Brazil

Biotech Clinical Research in Brazil

Biotech Clinical Research in Brazil

The Future of Biotech Clinical Research in Brazil

The future of biotech clinical research in Brazil holds great promise. As the country continues to invest in healthcare infrastructure and research capabilities, it will become an even more attractive destination for clinical trials. Here are some key trends and developments to anticipate:

  1. Increased Investment: Brazil is expected to attract more investments in biotech research, leading to the expansion of clinical trial capabilities and infrastructure.
  2. Emerging Biotech Hubs: Cities like São Paulo, Rio de Janeiro, and Belo Horizonte are emerging as biotech hubs, drawing both domestic and international companies.
  3. Digital Transformation: Brazil is embracing digital healthcare solutions, facilitating remote monitoring and data collection for clinical trials.
  4. Genomic Research: Genomic studies and precision medicine research are gaining traction in Brazil, offering new avenues for biotech research and personalized healthcare.
  5. Government Support: Continued government support, including incentives and regulatory reforms, is expected to further stimulate the biotech sector.


Biotech clinical research in Brazil is experiencing rapid growth, driven by its strategic advantages, cost-efficiency, and expanding research capabilities. While challenges exist, the benefits of conducting trials in Brazil, including a diverse patient pool, efficient recruitment processes, and a supportive regulatory environment, outweigh the obstacles.

As Brazil’s biotech sector continues to evolve and expand, it holds immense potential for companies seeking to make groundbreaking discoveries and introduce innovative therapies to the market. Brazil is poised to play a pivotal role in shaping the future of biotech clinical research, contributing to global advancements in healthcare and medicine.

Biotech Clinical Research in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Biotech Clinical Research in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Biotech Clinical Research in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Biotech Clinical Research in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Biotech Clinical Research in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Biotech Clinical Research in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Biotech Clinical Research in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Biotech Clinical Research in Brazil

The Cohortias Team

Biotech Clinical Research in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Biotech Clinical Research in Brazil

Network & Partnerships